From the New World cover image

Arnold Kling: How Economics Starts with Specialization

From the New World

00:00

The Benefits of Slow Approval for Vaccines

FDA restrictions or regulations on vaccines are beneficial to legacy drug companies like Pfizer, he says. "I think it gives more credibility to the approval and it also makes it harder for competitors to come in"

Play episode from 01:31:56
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app